
Opinion|Videos|August 23, 2024
Innovations Associated With IV Biologics
Author(s)Jennifer Seminerio, MD
Dr. Seminerio uncovers what excited her about IV biologics when they first came to market.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What about IV biologics excited you the most when they came out? What were your main concerns?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Lipfendra, first oral PCSK9 inhibitor
2
How the most favored nation drug pricing policy is quietly reshaping drug development and clinical research
3
Capital Rx is now Judi Rx in a company rebrand
4
FTC secures settlement with Caremark, locks in up to $8.5 billion in consumer savings
5





























